Molecular diagnosis of 5α-reductase type ii deficiency in Brazilian siblings with 46,XY disorder of sex development

6Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

The steroid 5α-reductase type II enzyme catalyzes the conversion of testosterone (T) to dihydrotestosterone (DHT), and its deficiency leads to undervirilization in 46,XY individuals, due to an impairment of this conversion in genital tissues. Molecular analysis in the steroid 5α-reductase type II gene (SRD5A2) was performed in two 46,XY female siblings. SRD5A2 gene sequencing revealed that the patients were homozygous for p.Gln126Arg missense mutation, which results from the CGA > CAA nucleotide substitution. The molecular result confirmed clinical diagnosis of 46,XY disorder of sex development (DSD) for the older sister and directed the investigation to other family members. Studies on SRD5A2 protein structure showed severe changes at NADPH binding region indicating that structural modeling analysis can be useful to evaluate the deleterious role of a mutation as causing 5α-reductase type II enzyme deficiency. © 2011 by the authors; licensee MDPI, Basel, Switzerland.

Cite

CITATION STYLE

APA

de Calais, F. L., Soardi, F. C., Petroli, R. J., Lusa, A. L. G., de Paiva e Silva, R. B., Maciel-Guerra, A. T., … de Mello, M. P. (2011). Molecular diagnosis of 5α-reductase type ii deficiency in Brazilian siblings with 46,XY disorder of sex development. International Journal of Molecular Sciences, 12(12), 9471–9480. https://doi.org/10.3390/ijms12129471

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free